Clinical associations and prognostic significance of serum anti-p53 antibodies in Thai patients with hepatocellular carcinoma

Asian Pacific Journal of Allergy and Immunology

Volumn 18, Issue 4, 2000, Pages 237-243

  Tangkijvanich, P ^a   Janchai, A ^a   Charuruks, N ^a   Kullavanijaya, P ^a   Theamboonlers, A ^a   Hirsch, P ^a   Poovorawan, Y ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; PROTEIN ANTIBODY; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD ANALYSIS; CANCER STAGING; CANCER SURVIVAL; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GENE MUTATION; HUMAN; IMMUNE RESPONSE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PORTAL VEIN THROMBOSIS; PROGNOSIS; PROTEIN BLOOD LEVEL; REGRESSION ANALYSIS; SURVIVAL RATE; THAILAND; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, NEOPLASM; CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; SURVIVAL RATE; THAILAND; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0034459399     PISSN: 0125877X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. The hepatitis B virus and hepatocellular carcinoma
2. Hepatocellular carcinoma: From gene to public health
3. Liver cancer in Thailand: Temporal and geographic variations
4. Natural history of untreated primary hepatocellular carcinoma: A restrospective study of 157 patients
5. The p53 tumor suppressor gene
6. Clinical implications of p53 tumor-suppressor gene
7. Mutational hot spot in the p53 gene in human hepatocellular carcinoma
8. Tumor progression in hepatocellular carcinoma may be mediated by p53 mutation
9. p53 overexpression is frequent in European hepatocellular carcinoma and largely independent of the codon 249 hot spot mutation
10. WAF1, a potential mediator of p53 tumor suppression
11. Cancer progression and p53
12. Multifactorial analysis of p53 alteration in human cancer: A review
13. Analysis of p53 of antibodies in patients with various cancers define B-cell epitopes of human p53: Distribution on primary structure and exposure on protein surface
14. The humoral immune response to p53 in patients with hepatocellular carcinoma is specific for malignancy and independent of alpha-fetoprotein status
15. Prevalence of serum antibodies against the p53 tumor suppressor gene protein in various cancer
16. p53 antibodies in the sera of lung cancer patients: Comparison with p53 mutation in the tumor tissue
17. The relationship between serum p53 autoantibodies and characteristics of human breast cancer
18. Serum antibodies against p53 in relation to cancer risk and prognosis in breast cancer: A population-based epidemiological study
19. Antibodies against p53 are associated with poor prognosis of colorectal cancer
20. Increased serum p53 antibody levels indicate poor prognosis in patients with colorectal cancer
21. Serum anti-p53 antibodies in gastric adenocarcinoma patients are associated with poor prognosis, lymph node metastasis and poorly differentiated nuclear grade
22. Prognostic significance of serum anti-p53 antibody in patients with hepatocellular carcinoma
23. Clinical significance of circulating anti-p53 antibodies in European patients with hepatocellular carcinoma
24. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa
25. p53 mutations and aflatoxin B1 exposure in hepatocellular carcinoma patients from Thailand
26. Mutation pattern of the p53 gene as a diagnostic marker for multiple hepatocellular carcinoma
27. p53 Abnormalities in hepatocellular carcinoma from United States patients: Analysis of all 11 exons
28. Use of specific ELISA for the detection of antibodies directed against p53 protein in patients with hepatocellular carcinoma
29. Tumor-suppressor p53: Implications for tumor development and prognosis
30. The clinical significance of p53 gene mutation in hepatocellular carcinoma from Japan
31. Assessment of the biological malignancy of hepatocellular carcinoma: Relationship to clinicopathological factors and prognosis
32. p53 mutation is a poor prognostic indicator for survival in patients with hepatocellular carcinoma undergoing surgical tumor ablation
33. The significance of p53 mutations as an indicator of the biological behavior of recurrent hepatocellular carcinomas
34. Determination of the oncogenes p53 and C-erb B2 in the tumour cytosols of advanced hepatocellular carcinoma (HCC) and correlation to survival time
35. Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers
36. Development of antibodies against p53 in lung cancer patients appears to be dependent on the type of p53 mutation
37. Genetic heterogeneity of hepatocellular carcinoma
38. Functional inactivation but not structural mutation of p53 causes liver cancer
39. Integrity of p53 in hepatitis B X antigen-positive and -negative hepatocellular carcinomas
40. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis